tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CareRx Q2 2024: Revenue Up, Adjusted EBITDA Grows

Story Highlights
CareRx Q2 2024: Revenue Up, Adjusted EBITDA Grows

CareRx (TSE:CRRX) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CareRx Corporation reported a mixed financial performance for Q2 2024 with a revenue of $92.0 million and an increased adjusted EBITDA of $7.5 million, despite facing a net loss of $1.4 million. The company remains committed to improving productivity and managing costs, while capitalizing on growth opportunities in the seniors living sector.

For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1